A major advance in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This essential malignant suppressor protein is frequently disabled in several kinds of tumors, leading https://social-galaxy.com/story7525253/mini-antibodies-restore-tumor-suppressor-p53-a-promising-approach-for-tumor-management